New chemo dosing shows promise for kids with rare cancers
NCT ID NCT01760226
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 35 times
Summary
This study tested a new way of giving chemotherapy (called dose-adjusted EPOCH-R) to children with certain B-cell cancers, including lymphoma and post-transplant disorders. The goal was to see if this approach, which worked well in adults, could improve cure rates while causing fewer side effects in children. Only 4 children took part, and the focus was on safety and how well the body handled the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.